Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Fernas
    Member
    • Apr 2013
    • 74

    #1

    RNASeq Biological Replicates

    Hi all,

    I have RNASeq data for 20 different samples (human cell types and tissues). 10 of these samples are represented by single biological replicate, while, the other 10 samples are represented by >=2 biological replicates. In total I have 40 RNASeq fastq files mapped independently.

    Now, the purpose is to compare the samples (cell types) against each other (not between the biological replicates of each sample). So, my question is: how can I deal with the biological replicates that I mapped? I have some options:

    1) Take one (random) replicate per sample
    2) Generate read count of mapped reads for all replicates per sample independently and then average the read counts
    3) Merge the mapped reads (using bedtools merge) of the replicates

    Any other suggestion?
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    Don't use any of the options you presented. You absolutely want to use the replicates as replicates to better gauge biological variability. You'll be using one of the normal RNAseq packages (DESeq2, edgeR, limma, etc.), which can handle replicates natively. The problem is actually the comparison of unreplicated samples, for which the results will be questionable.

    Comment

    • Fernas
      Member
      • Apr 2013
      • 74

      #3
      Thanks @dpryan.
      But actually my initial purpose of this study is not to study (differentially expressed genes) but to compare the gene profile (list of gene expression values in all the 20 cell types) against the histone modification profile (and some other epigenomic markers) which do not have replicates for these cell types. So, replicates here look useless. Am I right?
      Last edited by Fernas; 05-20-2014, 04:15 AM.

      Comment

      • dpryan
        Devon Ryan
        • Jul 2011
        • 3478

        #4
        No, more replicates will still give you a better idea of actual correlation, since you'll be more accurately assessing expression level (and how much histone modification or whatever is actually present). My guess (since you really don't provide enough information for people to know what you're actually attempting) is that you just want to use something like GSEA and look at gene-sets comprised of those genes whose promoters/bodies/whatever show enrichment for your histone modification(s) of interest across groups.

        Comment

        • Fernas
          Member
          • Apr 2013
          • 74

          #5
          Many thanks @dpryan for the prompt reply.
          I am sorry if I missed some information. I just wanted to make my question simple. What I want exactly to do is:
          to find the expression profile (vector of 20 values for 20 cell types) at each genomic region (e.g. promoter) and compare it with the epigenomic profile (vector of 20 values of histone modification marker or methylation..etc for 20 cell types) in order to detect those regions that have strong correlation.

          So, your point is to keep the replicates. In this case, I will need to use the same epigenomic value (histone modification value or methylation..etc) with the n replicates of the same cell type.

          I am not sure if GSEA Can do this task for me?

          Comment

          • dpryan
            Devon Ryan
            • Jul 2011
            • 3478

            #6
            I believe it can, yes.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM
            • SEQadmin2
              New Genomics Technologies Take Aim at Long-Standing Limits
              by SEQadmin2


              Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

              We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
              ...
              09-28-2026, 10:25 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Yesterday, 10:52 AM
            0 responses
            9 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-14-2026, 05:39 AM
            0 responses
            19 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-13-2026, 09:56 AM
            0 responses
            16 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-09-2026, 11:14 AM
            0 responses
            27 views
            0 reactions
            Last Post SEQadmin2  
            Working...